Daphne Karydas's Net Worth
$0
Who is Daphne Karydas?
Daphne Karydas does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Syndax Pharmaceuticals Inc, LogicBio Therapeutics, Inc., Eucrates Biomedical Acquisition Corp., COMPASS Pathways plc, and Mineralys Therapeutics, Inc..
SEC CIK
Daphne Karydas's CIK is 0001816952
Past Insider Trading and Trends
2021 was Daphne Karydas's most active year for acquiring shares with 2 total transactions. Daphne Karydas's most active month to acquire stocks was the month of May. 2022 was Daphne Karydas's most active year for disposing of shares, totalling 1 transactions. Daphne Karydas's most active month to dispose stocks was the month of October. 2021 saw Daphne Karydas paying a total of $0.00 for 107,500 shares, this is the most they've acquired in one year. In 2022 Daphne Karydas cashed out on 12,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.415
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
LogicBio Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Eucrates Biomedical Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COMPASS Pathways plc (CMPS) Snapshot price: $10.29
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mineralys Therapeutics, Inc. (MLYS) Snapshot price: $12.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
No matching records found |